Gerard Sanacora is a Psychiatry physician affiliated with Yale New Haven Hospital. OpenAlex indexes 289 publications with 34,179 citations (h-index 86); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
34 Park St
Cnru At Cmhc
New Haven, CT 065191109
Telephone
203-974-7560Registry record last updated 8 Jul 2007.
Clinical trials
- The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Sponsor: Yale University
- Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
Sponsor: Yale University
- AZD6765 Severe Major Depressive Disorder (MDD) IV
Sponsor: AstraZeneca
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202512 payments
- Supernus Pharmaceuticals, Inc.Program year20251 payment
- Eli Lilly and CompanyProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
8 NIH research awards on record, funded 1999–2014 per NIH RePORTER. The latest:
- Ex Vivo Assay for In Situ Brain-Wide Mapping of Glutamate/GABA Metabolism
Yale University
FY2014$515,895R01MH095104 - Ex Vivo Assay for In Situ Brain-Wide Mapping of Glutamate/GABA Metabolism
Yale University
FY2013$495,802R01MH095104 - Effects of Stress and Glutamatergic Agents on Glutamate Cycling and Behavior
Yale University
FY2013$351,691R01MH081211
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
New England Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
John Elefteriades, MD
Yale New Haven Hospital
Jeptha Curtis, MD
Yale New Haven Hospital
Erica Spatz, MD
Yale New Haven Hospital
Rohan Khera, MD
Yale New Haven Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”